Institutional Investor Files to Resell All 2.56M Shares of IonQ Common Stock
IONQ sits 90% above its 52-week low of $17.88.
Summary
An institutional investor, The Chancellor, Masters, and Scholars of the University of Cambridge, has filed to resell all of its 2.56 million shares of IonQ common stock, with the company receiving no proceeds from the sale.
Key Events · Financing and Capital Events · IONQ
-
Institutional Investor Divests Entire Stake
The Chancellor, Masters, and Scholars of the University of Cambridge is offering to sell all 2,562,642 shares of IonQ common stock it beneficially owns.
-
No Proceeds to Company
IonQ will not receive any funds from the sale of these shares, as the offering is solely for the benefit of the selling stockholder.
-
Potential Market Overhang
The availability of a block of shares for resale could contribute to selling pressure on IonQ's stock.
Analysis · IONQ · Technology
This 424B7 prospectus supplement details the intent of a significant institutional investor, The Chancellor, Masters, and Scholars of the University of Cambridge, to sell its entire holding of 2,562,642 shares of IonQ common stock. While the offering represents approximately 0.72% of IonQ's current market capitalization, the complete divestment by a named institutional holder is a notable event. The company will not receive any proceeds from these sales, which could create an overhang on the stock as these shares become available for trading. This follows previous resale filings under the same shelf registration.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 29.9% of the 1678 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.25%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IONQ was trading at $34.01 on NYSE in the Technology sector, with a market capitalization of approximately $12.5B. The 52-week trading range was $17.88 to $84.64. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.